Clinical predictors of survival for patients with atypical teratoid/rhabdoid tumors

[1]  Sandeep Kumar Dhanda,et al.  Relevance of Molecular Groups in Children with Newly Diagnosed Atypical Teratoid Rhabdoid Tumor: Results from Prospective St. Jude Multi-institutional Trials , 2021, Clinical Cancer Research.

[2]  T. Niazi,et al.  Age of diagnosis clinically differentiates atypical teratoid/rhabdoid tumors diagnosed below age of 3 years: a database study , 2020, Child's Nervous System.

[3]  H. Koo,et al.  Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System in Children under the Age of 3 Years , 2020, Cancer research and treatment : official journal of Korean Cancer Association.

[4]  J. Finlay,et al.  Meta-Analysis of Treatment Modalities in Metastatic Atypical Teratoid/Rhabdoid Tumors in Children. , 2020, Pediatric neurology.

[5]  Derek W. Yecies,et al.  Locoregionally administered B7-H3-targeted CAR T cells for treatment of atypical teratoid/rhabdoid tumors , 2020, Nature Medicine.

[6]  Zarina S Ali,et al.  Association of spinal instability due to metastatic disease with increased mortality and a proposed clinical pathway for treatment. , 2020, Journal of neurosurgery. Spine.

[7]  K. Usami,et al.  Neoadjuvant chemotherapy for atypical teratoid rhabdoid tumors (AT/RTs) , 2019, Child's Nervous System.

[8]  Y. Arakawa,et al.  Clinical characteristics, treatment, and survival outcome in pediatric patients with atypical teratoid/rhabdoid tumors: a retrospective study by the Japan Children's Cancer Group. , 2019, Journal of neurosurgery. Pediatrics.

[9]  Zaid A. Siddiqui,et al.  Trimodality therapy for atypical teratoid/rhabdoid tumor is associated with improved overall survival: A surveillance, epidemiology, and end results analysis , 2019, Pediatric blood & cancer.

[10]  J. Biegel,et al.  Case-based review: atypical teratoid/rhabdoid tumor. , 2018, Neuro-oncology practice.

[11]  M. Karsy,et al.  Patient-Level Factors Influencing Hospital Costs and Short-Term Patient-Reported Outcomes After Transsphenoidal Resection of Sellar Tumors , 2018, Neurosurgery.

[12]  K. Auguste,et al.  Complications following pediatric cranioplasty after decompressive craniectomy: a multicenter retrospective study. , 2018, Journal of neurosurgery. Pediatrics.

[13]  A. Huang,et al.  Atypical Teratoid Rhabdoid Tumour : From Tumours to Therapies , 2018, Journal of Korean Neurosurgical Society.

[14]  D. Shrieve,et al.  Anaplastic meningioma: an analysis of the National Cancer Database from 2004 to 2012. , 2017, Journal of neurosurgery.

[15]  J. Finlay,et al.  Marrow-ablative chemotherapy followed by tandem autologous hematopoietic cell transplantation in pediatric patients with malignant brain tumors , 2017, Bone Marrow Transplantation.

[16]  A. King,et al.  Assessment of the treatment approach and survival outcomes in a modern cohort of patients with atypical teratoid rhabdoid tumors using the National Cancer Database , 2017, Cancer.

[17]  D. Johnston,et al.  Atypical teratoid rhabdoid tumor in the first year of life: the Canadian ATRT registry experience and review of the literature , 2017, Journal of Neuro-Oncology.

[18]  Brandon A. Sherrod,et al.  Risk factors for unplanned readmission within 30 days after pediatric neurosurgery: a nationwide analysis of 9799 procedures from the American College of Surgeons National Surgical Quality Improvement Program. , 2016, Journal of neurosurgery. Pediatrics.

[19]  R. Prayson,et al.  Lumbar spinal atypical teratoid rhabdoid tumor , 2015, Journal of Clinical Neuroscience.

[20]  Christine S. M. Lau,et al.  Atypical teratoid rhabdoid tumors: a population-based clinical outcomes study involving 174 patients from the Surveillance, Epidemiology, and End Results database (1973–2010) , 2015, Cancer management and research.

[21]  T. Kurth,et al.  The Deyo-Charlson and Elixhauser-van Walraven Comorbidity Indices as predictors of mortality in critically ill patients , 2015, BMJ Open.

[22]  S. Sredni,et al.  Rhabdoid Tumor Predisposition Syndrome , 2015, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.

[23]  D. Johnston,et al.  Central nervous system atypical teratoid rhabdoid tumours: the Canadian Paediatric Brain Tumour Consortium experience. , 2012, European journal of cancer.

[24]  C. Rodríguez-Galindo,et al.  Age, stage, and radiotherapy, but not primary tumor site, affects the outcome of patients with malignant rhabdoid tumors , 2010, Pediatric blood & cancer.

[25]  J. Biegel,et al.  Intensive multimodality treatment for children with newly diagnosed CNS atypical teratoid rhabdoid tumor. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  T. Merchant,et al.  Atypical teratoid/rhabdoid tumors (ATRT): improved survival in children 3 years of age and older with radiation therapy and high-dose alkylator-based chemotherapy. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.